Data protection Impressum

Oncology

Researchers from HUG and UNIGE have developed patient-derived lung cancer “mini-tumors” to rapidly identify the most effective personalized treatments.

Geneva team develops lung cancer “mini-tumors” to accelerate personalized treatments

13 August 2025

Two start-ups from Western Switzerland’s Health Valley, AzureCell Therapies and Myriad Optics, have each been awarded CHF 150,000 through the Gebert Rüf Stiftung’s Innobooster programme, which supports high-potential projects emerging from Swiss universities.

AzureCell Therapies and Myriad Optics awarded by Gebert Rüf Stiftung’s Innobooster programme

11 August 2025

Bern-based medtech Compremium is testing its compressibility-based device in patients with thyroid nodules to improve diagnostic precision and reduce unnecessary surgeries.

Compremium launches human study for non-invasive thyroid cancer diagnostic

15 July 2025

Vaud-based medtech Comphya strengthens its clinical pipeline with fresh capital and prepares for pivotal trials in the United States.

Comphya raises CHF 7.5 million for its neurostimulation therapy to treat erectile dysfunction

14 July 2025

Adiposs secures CHF 4 million to advance ImageBAT, a novel contrast agent using CT scans to predict cancer treatment response via brown fat imaging.

Adiposs raises CHF 4 million to advance brown fat imaging in cancer care

1 July 2025

Two high-potential start-ups from Western Switzerland, HAYA Therapeutics and Neural Concept, have been named among the World Economic Forum’s 100 Technology Pioneers of 2025.

Two Lausanne-based start-ups named WEF Technology Pioneers in 2025

30 June 2025

Top Stories Western Switzerland

Top Stories from Western Switzerland (June 2025)

25 June 2025

The Lausanne University Hospital (CHUV) strengthens its oncology network with the launch of a dedicated bladder cancer center offering personalized, high-level treatment and coordinated support.

CHUV opens new bladder cancer center combining advanced care and interdisciplinary expertise

16 June 2025

Western Switzerland is rapidly becoming a hotspot for biomanufacturing and life sciences companies, thanks to its strong infrastructure, skilled talent, and business-friendly policies. Yassin Nahi, GGBa (Greater Geneva Bern area) Life Science Director, shares how the region's research hubs, academic institutions, and regulatory support make it an ideal location for companies in this sector.

Why Western Switzerland for Biomanufacturing and Life Sciences Companies: an interview with expert Yassin Nahi

Hedera Dx has secured EUR 15 million to expand hospital-based cancer diagnostics, making precision oncology more accessible to patients worldwide.

Hedera Dx raises EUR 15 million to expand access to precision cancer care

27 May 2025

1 2 3 4 5 … 9